Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for November 2006. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Local Pain, Negative Affect Can Predict Fibromyalgia Pain
THURSDAY, Nov. 30 (HealthDay News) -- Overall fibromyalgia pain can be predicted by ratings of local body pain and pain-related negative affect, according to a report in the November issue of Rheumatology.
Abstract
Full Text (subscription or payment may be required)
Acetaminophen, NSAIDs Compared for Osteoarthritis
THURSDAY, Nov. 30 (HealthDay News) -- Acetaminophen may have anti-inflammatory properties that are similar to non-steroidal anti-inflammatory drugs (NSAIDs) in osteoarthritic knees, according to the findings of a small, uncontrolled pilot study published in the November issue of the journal Rheumatology.
Abstract
Full Text (subscription or payment may be required)
Long-Term Ankylosing Spondylitis Linked to Cachexia
THURSDAY, Nov. 30 (HealthDay News) -- Patients with long-standing ankylosing spondylitis and resulting radiological changes show evidence of cachexia compared to controls without the disease, according to a report in the November issue of the journal Rheumatology.
Abstract
Full Text (subscription or payment may be required)
Rheumatoid Arthritis Drugs May Boost Cardiovascular Risk
THURSDAY, Nov. 30 (HealthDay News) -- Biologic immunosuppressive agents do not affect the risk of cardiovascular events in patients with rheumatoid arthritis, but the risk increases by 30 percent to 80 percent in patients taking glucocorticoids or cytotoxic immunosuppressive drugs, according to study findings published in the December issue of Arthritis & Rheumatism.
Abstract
Full Text (subscription or payment may be required)
Psoriasis Plaque Thickness Linked to Disease Traits
WEDNESDAY, Nov. 22 (HealthDay News) -- The thickness of psoriatic plaques may be associated with other psoriasis presentations and may help to shed light on its genetic characteristics, according to a report in the November issue of the Journal of Investigative Dermatology.
Abstract
Full Text (subscription or payment may be required)
One in Four U.S. Adults Recently Affected by Pain
THURSDAY, Nov. 16 (HealthDay News) -- Recent and chronic pain afflict a large proportion of the U.S. adult population, according to Health, United States, 2006, a report published Nov. 15 by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics (NCHS). One in four U.S. adults have suffered a bout of pain in the last month, and one in 10 report that the pain has lasted for at least a year.
More Information
ACR: Lifetime Risk of Osteoarthritis is 24 Percent
WEDNESDAY, Nov. 15 (HealthDay News) -- Almost one in four people who live to the age of 85 will develop osteoarthritis, and the risk for those who are obese is more than one in three, according to a paper presented at the American College of Rheumatology Annual Scientific Meeting held Nov. 10-15 in Washington, D.C.
Abstract
ACR: Ankylosing Spondylitis Protein Marker Identified
WEDNESDAY, Nov. 15 (HealthDay News) -- In ankylosing spondylitis patients, the protein marker matrix metalloproteinase 3 (MMP3) is a significant predictor of joint damage, according to a paper presented at the American College of Rheumatology Annual Scientific Meeting held Nov. 10-15 in Washington, D.C.
Abstract
Musculoskeletal Disorders Affect Quality of Life
FRIDAY, Nov. 10 (HealthDay News) -- Patients with ankle osteoarthritis have physical impairments affecting their quality of life similar to patients with other severe medical problems, according to study findings published in the Nov. 1 issue of the Journal of Bone & Joint Surgery.
Abstract
Full Text (subscription or payment may be required)
Acupuncture May Benefit Osteoarthritis Patients
WEDNESDAY, Nov. 1 (HealthDay News) -- In patients with osteoarthritis of the knee or hip, acupuncture in addition to routine care may result in significant clinical improvement, researchers report in the November issue of Arthritis & Rheumatism.
Abstract
Full Text (subscription or payment may be required)
Editorial
Turmeric Seen as Potential Rheumatoid Arthritis Therapy
WEDNESDAY, Nov. 1 (HealthDay News) -- A turmeric extract may improve symptoms of rheumatoid arthritis through an identifiable mechanism, according to the results of an animal study published in the November issue of Arthritis & Rheumatism.
Abstract
Full Text (subscription or payment may be required)
